Claris Lifesciences, a Rs. 725 crore plus Ahmedabad based pharma major, has entered into definitive agreements with Baxter International Inc for the sale of its global generic injectables business for a total gross consideration of Rs. 4,230 crore ... PharmaBiz, 1 month ago
Claris Lifesciences sells injectables biz to Baxter for Rs 4,237 crore - Smart Investor, 1 month ago
on your WebpageAdd Widget >Get your members hooked!